Funnel plots of publication bias. by Beshada Zerfu Woldegeorgis (12916598)

Subjects:

Risk of bias assessment result. by Robin Novriansyah (18127530)

“…No predictor reached statistical significance for HHS or THA conversion. However, mean age showed a borderline significant association with VAS (coefficient = −0.8029; P = 0.065), suggesting a possible trend of more significant pain reduction in older patients.…”

Both cis- and trans-cycles decrease in number upon treatment with auxin. by Manu Aggarwal (15990691)

Summary of significant LMM coefficients and contrasts on log-transformed RTs. by Arianna Compostella (8843135)

Funnel plot of the included studies. Egger’s test did not indicate significant publication bias (z  = −1.0148, p = 0.3102). by Megan Doyle (14583058)

Phenotype and molecular identification of <i>GmNN1/FT2a</i> in stable transgenic soybean plants. by Xinxin Li (281237)

Survival analysis in denosumab users versus non-users. by Arisa Kobayashi (4379608)

PA psychological correlates direction of effect results sorted by risk of bias and type of apps. by Zihao He (8780582)

QUADAS-2 risk of bias and applicability of selected studies. by V. Abeysuriya (11985239)

Risk of bias. by Joel D’Souza (6900548)

“…In addition, their successful prediction remains elusive due to significant heterogeneity in this field of research. …”

Results of the RCTs risk of bias judgments about each risk of bias item for each included trail. by Zhengfa Han (14434281)

Results of the RCTs risk of bias: Judgments about each risk of bias item for each included trail. by Zhengfa Han (14434281)

Judgement of risk of bias which was assessed according to the Cochrane’s risk of bias tool V2 for RCTs. by Xue Li (285380)

Risk of bias assessment. by Edward Kurnia Setiawan Limijadi (18692700)

“…Analysis of BRCA1 and BRCA2 administration’s impact on odds ratio (OR) based on six and five studies respectively. BRCA1 exhibited non-significant effects (OR = 1.26, P = 0.51), while BRCA2 showed significance (OR = 1.68, P = 0.04). …”

Risk of bias graph and summary. by Junjie Zhou (3985985)

“…The inclusion criteria were established via the PICOS framework. The risk of bias was assessed with the Cochrane risk-of-bias tool, and the certainty of the evidence was assessed via the GRADE approach. …”

CASP risk of bias assessment. by Madina Syzdykova (21161836)

“…<div><p>Bronchopulmonary dysplasia (BPD) presents a significant respiratory challenge in infants born prematurely. …”

The RPL estimation results in the main effect with interaction (Model 2) (Only significant variables). by Keiko Aoki (10535562)

Risk of bias assessment using the Cochrane risk of bias assessment tool (RoB 2). by Alain Nahaskida (21474469)

Publication bias using Egger’s test. by Muluneh Assefa (12029676)

Subjects:

Risk of bias assessment and reasons for exclusion. by Min Sun (115484)